CHRISTOPHER M. BLAND, Pharm.D., BCPS, FIDSA, FCCP

Clinical and Administrative Pharmacy, Savannah
Albert W. Jowdy Professor in Pharmacy Care

Curriculum Vitae

Clinical and Administrative Pharmacy, Savannah

Education

Doctor of Pharmacy, University of South Carolina, College of Pharmacy 2000

Areas of Expertise

Research Areas: Critical care, Infectious Diseases, drug dosing in obesity, antimicrobial stewardship

Opportunities for Collaboration: Synergy and collaboration among faculty who research in critical care or Infectious Diseases areas

Honors, Awards, and Achievements

College of Pharmacy Teacher of the Year 2018

Fellow of the American College of Clinical Pharmacy, 2016

Fellow of the Infectious Diseases Society of America, 2015

Department of the Army Commander’s Award for Civilian Service, 2015

GSHP Best Paper Describing a New Pharmaceutical Care Service Award, 2013

Ralph D. Arnold Army Pharmacy Research Award, 2012

Board Certified Pharmacotherapy Specialist (BCPS), 2003-present

University of Georgia College of Pharmacy Preceptor of Year, 2005-06

Affiliations
Research Interests
  1. Antimicrobial Dosing within Critically Ill Patients
  2. Drug Dosing in Obesity
  3. Personal Finance within Healthcare Professionals and Trainees
Selected Publications

Books

Bland CM, Branan TB, Hawkins WA, Sikora A, Smith SE. InteGREAT: A Guidebook for Creating Great Healthcare Teams. April 18, 2024. ISBN# 194666570.

Sutton SS, Bland CM, El-Ibiary S, Hecht KA. McGraw Hill’s Naplex Review Guide, 5th edition. McGraw Hill; 2024.

Peer-Reviewed Publications

Bland CM, Branan TN, Ostendorf C, Smith SE. IV Push Cefepime for Pseudomonas aeruginosa in Critically Ill Patients? Convenience over Quality Care? Am J Health Syst Pharm. In Press June 2025.

Nguyen J, Madonia V, Bland CM, Stover KR, Eiland LS, Keating J, Lemmon M, Bookstaver PB. A Review of Antibiotic Safety in Pregnancy- 2025 Update. Pharmacotherapy. 2025;45:227-237.

Sherman ER, Ta NH, Branan TN, Patimavirujh N, Dickinson LA, Bland CM, Smith SE. Evaluation of the Efficacy of Intravenous Push and Intravenous Piggyback Ceftriaxone in Critically Ill Patients. Antibiotics (Basel). 2024;13:921.

Smith SE, Bland CM, Branan TB, Sikora A, Hawkins WA. Research and Scholarly Methods: Research Collaboration. J Am Coll Clin Pharm. 2024;7:1122-1132.

Loudermilk C, Eudy J, Albrecht S, Slaton CN, Stramel S, Tu P, Albrecht B, Green SB, Bouchard JL, Orvin AI, Caveness CF, Newsome AS, Bland CM, Bookstaver PB, Anderson DT, on behalf of the Southeastern Research Group Endeavor (SERGE-45). Evaluation of Sequential Oral Versus Intravenous Antibiotic Treatment of Enterococcus faecalis Bloodstream Infections. Ann Pharmacother. 2025;59:127-133.

Bland CM, Heil E, Asbell A, Smith SE, Jones BM. De-labeling for the duration? Beta-lactam prescribing in patients after penicillin skin testing. J Allergy Clin Immunol Pract. 2023 Jun 16: S2213-2198(23)00663-3.

Smith SE, Smith M, Bland CM. Perceptions and knowledge of personal finance in doctor of pharmacy versus undergraduate students: more wisdom or just more debt? Curr Pharm Teach Learn. 2023;15:473-482.

Jones BM and Bland CM. Implementing De-labeling of Beta-lactam Allergies: Getting to the Why? Clin Infect Dis. 2023;77:23-24.

Bland CM, Pai A, Lodise TP. Reappraisal of Contemporary Pharmacokinetic/Pharmacodynamic Principles for Informing Aminoglycoside Dosing. Pharmacotherapy. 2018;38:1229-1238.

Gallagher JC, Satlin MJ, Elabor A, Saraiya N, McCreary EK, Molnar E, El-Beyrouty C, Jones BM, Dixit D, Heil EL, Claeys KC, Hiles J, Vyas NM, Bland CM, Suh J, Biason K, McCoy D, King MA, Richards L, Harrington N, Guo Y, Chaudhry S, Lu X, Yu D. Ceftolozane-tazobactam for the treatment of multidrug-resistant Pseudomonas aeruginosa infections: A multicenter study. Open Forum Infectious Diseases. 2018:ofy280.  doi:10.1093/ofid/ofy280.

Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A review of antibiotic use in pregnancy. Pharmacotherapy 2015;35:1052-62.

Bland CM, Bookstaver PB, Lu ZK, Dunn BL, Rumley KF. Musculoskeletal Safety Outcomes of Patients Receiving Daptomycin with HMG-CoA Reductase Inhibitors. Antimicrob Agents Chemother. 2014;58:5726-31.


Why Pharmacy at UGA?

Ranked 15th out of 141 pharmacy programs in the country by US News & World Report, UGA Pharmacy is at the top of its class. Learn more below:

Start your Pharmacy Journey

Apply Today Get More Info